Collectively, these results suggested that αCD4 treatment, but not mH treatment, play a major role in the expansion of CD8+ T cells in draining lymph node, and that mH treatment, when combined with αCD4 treatment, synergistically increases the number of CD8+ T cells in the tumor. Here, CD8A is linked to neoplasm.